drinking semaglutide Weight loss drug may reduce alcohol cravings, heavy and smoking, new study finds Dr. - The blockbuster drug

By acting on GLP-1 receptors in the brain, semaglutide decreases hunger and enhances satiety, leading individuals to consume fewer calories

Because both medications slow gastric emptying, they can cause nausea, vomiting, and digestive discomfort

Inject into healthy skin and avoid problem areas: Do not inject into bruised, sore, hard, red or broken skin

Treat it as a maintenance fiber to introduce gradually once your gut has settled, not a first-line choice for the acute phase

Starting July 2026, Wegovy is also one of the three drugs covered under the GLP-1 Bridge program for weight loss at a $50/month copay, manufactured by Novo Nordisk